Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: Significance for blood flow modification

Tozer, G. M., Prise, V. E., Bell, K. M. et al. (3 more authors) (1996) Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: Significance for blood flow modification. British Journal of Cancer, 74 (12). pp. 1955-1960. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Tozer, G. M.
  • Prise, V. E.
  • Bell, K. M.
  • Dennis, M. F.
  • Stratford, M. R. L.
  • Chaplin, D. J.
Copyright, Publisher and Additional Information: © 1996 Stockton Press. Papers published under this licence are made freely available to all readers under a CC/BY-NC-SA/4.0 licence one year after publication in BJC
Keywords: P22 rat carcinosarcoma; tumour vascular resistance; nitric oxide; nitric oxide donors; isolated perfusion; endothelium-derived relaxing factor; NITRIC-OXIDE SYNTHASE; THERAPEUTIC GAIN; MURINE TUMOR; L-ARGININE; HYDRALAZINE; CANCER; PROLIFERATION; VASCULATURE; EXPRESSION; RELAXATION
Dates:
  • Published: December 1996
  • Accepted: 15 July 1996
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 16 Feb 2017 14:44
Last Modified: 16 Feb 2017 14:44
Published Version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20748...
Status: Published
Publisher: Cancer Research UK
Refereed: Yes

Share / Export